These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 25949914)
1. Wu D; Wu P; Wu X; Ye J; Wang Z; Zhao S; Ni C; Hu G; Xu J; Han Y; Zhang T; Qiu F; Yan J; Huang J Oncoimmunology; 2015 Mar; 4(3):e992749. PubMed ID: 25949914 [TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells. Fisher JP; Yan M; Heuijerjans J; Carter L; Abolhassani A; Frosch J; Wallace R; Flutter B; Capsomidis A; Hubank M; Klein N; Callard R; Gustafsson K; Anderson J Clin Cancer Res; 2014 Nov; 20(22):5720-32. PubMed ID: 24893631 [TBL] [Abstract][Full Text] [Related]
3. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells. Knight A; Mackinnon S; Lowdell MW Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570 [TBL] [Abstract][Full Text] [Related]
4. A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy. Ferry GM; Agbuduwe C; Forrester M; Dunlop S; Chester K; Fisher J; Anderson J; Barisa M Front Immunol; 2022; 13():863155. PubMed ID: 35711450 [TBL] [Abstract][Full Text] [Related]
5. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells. Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241 [TBL] [Abstract][Full Text] [Related]
6. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer. Rong L; Li K; Li R; Liu HM; Sun R; Liu XY World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849 [TBL] [Abstract][Full Text] [Related]
7. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy. Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998 [TBL] [Abstract][Full Text] [Related]
8. Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells Shimizu T; Tomogane M; Miyashita M; Ukimura O; Ashihara E Oncoimmunology; 2018; 7(5):e1424671. PubMed ID: 29721384 [TBL] [Abstract][Full Text] [Related]
9. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. Maeurer MJ; Martin D; Walter W; Liu K; Zitvogel L; Halusczcak K; Rabinowich H; Duquesnoy R; Storkus W; Lotze MT J Exp Med; 1996 Apr; 183(4):1681-96. PubMed ID: 8666926 [TBL] [Abstract][Full Text] [Related]
10. Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing. Hudecek R; Kohlova B; Siskova I; Piskacek M; Knight A Front Immunol; 2021; 12():752646. PubMed ID: 34691070 [TBL] [Abstract][Full Text] [Related]
11. GammadeltaT cells in juvenile idiopathic arthritis: higher percentages of synovial Vdelta1+ and Vgamma9+ T cell subsets are associated with milder disease. Berkun Y; Bendersky A; Gerstein M; Goldstein I; Padeh S; Bank I J Rheumatol; 2011 Jun; 38(6):1123-9. PubMed ID: 21406498 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy. Sato K; Kimura S; Segawa H; Yokota A; Matsumoto S; Kuroda J; Nogawa M; Yuasa T; Kiyono Y; Wada H; Maekawa T Int J Cancer; 2005 Aug; 116(1):94-9. PubMed ID: 15756684 [TBL] [Abstract][Full Text] [Related]
13. Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B. Chang KM; Traum D; Park JJ; Ho S; Ojiro K; Wong DK; Wahed AS; Terrault NA; Khalili M; Sterling RK; Janssen HLA; Shuhart MC; Lau DT; Roberts LR; Johnson GS; Kaplan DE; Betts MR; Lee WM; Lok ASF; PLoS Pathog; 2019 Apr; 15(4):e1007715. PubMed ID: 30998783 [TBL] [Abstract][Full Text] [Related]
14. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies. Zhou J; Kang N; Cui L; Ba D; He W Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706 [TBL] [Abstract][Full Text] [Related]
15. Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression. Cuthbert RJ; Watad A; Fragkakis EM; Dunsmuir R; Loughenbury P; Khan A; Millner PA; Davison A; Marzo-Ortega H; Newton D; Bridgewood C; McGonagle DG Ann Rheum Dis; 2019 Nov; 78(11):1559-1565. PubMed ID: 31530557 [TBL] [Abstract][Full Text] [Related]
16. Dichotomous and stable gamma delta T-cell number and function in healthy individuals. Ou L; Wang H; Liu Q; Zhang J; Lu H; Luo L; Shi C; Lin S; Dong L; Guo Y; Huang L; Zhu J; Yin X; Huang AC; Karakousis G; Schuchter L; Amaravadi R; Zheng C; Fan Y; Guo W; Xu X J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011536 [TBL] [Abstract][Full Text] [Related]
17. Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood. Kang N; Zhou J; Zhang T; Wang L; Lu F; Cui Y; Cui L; He W Cancer Biol Ther; 2009 Aug; 8(16):1540-9. PubMed ID: 19471115 [TBL] [Abstract][Full Text] [Related]
18. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation. Kress E; Hedges JF; Jutila MA Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401 [TBL] [Abstract][Full Text] [Related]
19. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis. Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798 [TBL] [Abstract][Full Text] [Related]
20. Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Troye-Blomberg M; Worku S; Tangteerawatana P; Jamshaid R; Söderström K; Elghazali G; Moretta L; Hammarström M; Mincheva-Nilsson L Scand J Immunol; 1999 Dec; 50(6):642-50. PubMed ID: 10607313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]